Antifungal prophylaxis in hematopoietic stem cell transplant recipients

Research output: Contribution to journalReview articlepeer-review


Infections remain a major complication of hematopoietic stem cell transplantation, with recent trends indicating that fungal pathogens have become one of the most common causes of death. Attention has turned to the use of prophylactic antifungal medications to prevent infection with both Candida and Aspergillus species. Recent studies, which are reviewed within, indicate success in preventing infections caused by azole-susceptible Candida species, accompanied by improved transplant-related mortality rates in high-risk patients. Further studies are necessary to develop strategies to prevent infection with Aspergillus species.

Original languageEnglish (US)
Pages (from-to)423-426
Number of pages4
JournalCurrent opinion in infectious diseases
Issue number4
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Antifungal prophylaxis in hematopoietic stem cell transplant recipients'. Together they form a unique fingerprint.

Cite this